PCMH
ONC icon

Polymer Capital Management (HK)’s BeOne Medicines Ltd ONC Stock Holding History

Polymer Capital Management (HK)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,900
Closed -$460K – 293
2025
Q2 		$460K Buy
+1,900
New +$466K 0.07% 121
2024
Q2 		– Sell
-9,500
Closed -$1.49M – 262
2024
Q1 		$1.49M Buy
+9,500
New +$1.53M 0.37% 70

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Polymer Capital Management (HK)'s ONC Position: Q3 2025 in Review

Polymer Capital Management (HK) sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 1,900 shares — an estimated $460K sold.

Polymer Capital Management (HK) first reported a position in ONC in Q1 2024 and held it in 2 quarters. The position peaked at $1.49M in Q1 2024. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Polymer Capital Management (HK) reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Polymer Capital Management (HK) sold 1,900 BeOne Medicines Ltd shares in Q3 2025, an estimated $460K.
  • Polymer Capital Management (HK) first reported a position in BeOne Medicines Ltd in Q1 2024 and held it in 2 quarters.
  • Polymer Capital Management (HK)'s BeOne Medicines Ltd position peaked at $1.49M in Q1 2024.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Polymer Capital Management (HK)'s 13F filing for Q3 2025, filed 14 Nov 2025.